The paradox of dysfunctional high-density lipoprotein

Purpose of review This review addresses how, in atherosclerosis or systemic inflammation, HDL can lose its usual atheroprotective characteristics and even paradoxically assume proinflammatory properties. Recent findings Specific chemical and structural changes within HDL particles can impede reverse cholesterol transport, enhance oxidation of LDL, and increase vascular inflammation. HDL may be viewed as a shuttle that can be either anti-inflammatory or proinflammatory, depending on its cargo of proteins, enzymes, and lipids. Some therapeutic approaches that reduce coronary risk, such as statins and therapeutic lifestyle changes, can favorably moderate the characteristics of proinflammatory HDL. In addition, apolipoprotein A-I mimetic peptides and other compounds that target functional aspects of HDL may offer novel approaches to reduction in cardiovascular risk. Summary Current data suggest that under some conditions HDL can become dysfunctional and even proinflammatory, but this characterization can change with resolution of systemic inflammation or use of certain treatments.

[1]  D. Sviridov,et al.  Genetic factors affecting HDL levels, structure, metabolism and function , 2007, Current opinion in lipidology.

[2]  C. Jordan,et al.  Group V Secretory Phospholipase A2 Promotes Atherosclerosis: Evidence From Genetically Altered Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Tall,et al.  The failure of torcetrapib: was it the molecule or the mechanism? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[4]  G. Kaysen Disorders in high-density metabolism with insulin resistance and chronic kidney disease. , 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[5]  H. Pearson When good cholesterol turns bad , 2006, Nature.

[6]  Dan S. Tawfik,et al.  The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux Published, JLR Papers in Press, August 16, 2006.s⃞ , 2006, Journal of Lipid Research.

[7]  A. Nègre-Salvayre,et al.  Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. , 2006, Free radical biology & medicine.

[8]  G. Fonarow,et al.  High-density lipoprotein: Is it always atheroprotective? , 2006, Current atherosclerosis reports.

[9]  P. Barter,et al.  Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. , 2006, Journal of the American College of Cardiology.

[10]  K. Kalunian,et al.  Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[11]  G. Norata,et al.  Oxidized-HDL3 modulates the expression of Cox-2 in human endothelial cells. , 2006, International journal of molecular medicine.

[12]  M. Kamboh,et al.  Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[13]  Paul T. Tarr,et al.  ATP-binding cassette transporter G1 and lipid homeostasis , 2006, Current opinion in lipidology.

[14]  K. Wong,et al.  Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk. , 2006, Clinical biochemistry.

[15]  D. Sviridov,et al.  Elevated HDL Cholesterol is Functionally Ineffective in Cardiac Transplant Recipients: Evidence for Impaired Reverse Cholesterol Transport , 2006, Transplantation.

[16]  B. Lam,et al.  HDL dysfunction in obstructive sleep apnea. , 2006, Atherosclerosis.

[17]  C. Roberts,et al.  Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. , 2004, Journal of applied physiology.

[18]  A. Nègre-Salvayre,et al.  Structural modifications of HDL and functional consequences. , 2006, Atherosclerosis.

[19]  T. Delmonte,et al.  Evaluation of the Paraoxonases as Candidate Genes for Stroke: Gln192Arg Polymorphism in the Paraoxonase 1 Gene Is Associated With Increased Risk of Stroke , 2005, Stroke.

[20]  J. Shepherd Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes? , 2005, Atherosclerosis. Supplements.

[21]  S. Reddy,et al.  An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  S. Hazen,et al.  Formation of dysfunctional high-density lipoprotein by myeloperoxidase. , 2005, Trends in cardiovascular medicine.

[23]  A. Fogelman When pouring water on the fire makes it burn brighter. , 2005, Cell metabolism.

[24]  S. Reddy,et al.  The double jeopardy of HDL , 2005, Annals of medicine.

[25]  P. Barter The inflammation: lipoprotein cycle. , 2005, Atherosclerosis. Supplements.

[26]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[27]  P. Barter,et al.  Antiinflammatory Properties of HDL , 2004 .

[28]  Philippe Giral,et al.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.

[29]  A. Hamsten,et al.  Oxidised‐HDL3 induces the expression of PAI‐1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization , 2004, British journal of haematology.

[30]  S. Reddy,et al.  Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice , 2004, Circulation.

[31]  M. Hersberger,et al.  High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease , 2004, Current opinion in lipidology.

[32]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[33]  H. Brewer,et al.  High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[34]  E. D. de Faria,et al.  Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Shirin Rahmani,et al.  Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment , 2003, Circulation.

[36]  Katsutoshi Yamada,et al.  Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. , 2003, Biochimica et biophysica acta.

[37]  M. Hayden,et al.  Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 Gene , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[38]  A. Hamsten,et al.  Effects of HDL3 on the expression of matrix-degrading proteases in human endothelial cells. , 2003, International journal of molecular medicine.

[39]  C. Marchionni,et al.  Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity , 2001, Acta Diabetologica.

[40]  S. Reddy,et al.  A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. , 2001, Journal of lipid research.

[41]  D. Nayak,et al.  High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection , 2001, Circulation.

[42]  G. Franceschini,et al.  Cardiovascular Status of Carriers of the Apolipoprotein A-IMilano Mutant: The Limone sul Garda Study , 2001, Circulation.

[43]  S. Yamashita,et al.  Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. , 2000, Atherosclerosis.

[44]  Hans Lee,et al.  Determinants of Bioactivity of Oxidized Phospholipids: Specific Oxidized Fatty Acyl Groups at the sn-2 Position , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[45]  S. Reddy,et al.  Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.

[46]  J. Gamble,et al.  Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. , 2000, Journal of lipid research.

[47]  S.-M. Kim,et al.  Glycation impairs high-density lipoprotein function , 2000, Diabetologia.

[48]  G. Fonarow,et al.  formation of , 2022 .

[49]  James W. Anderson,et al.  Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[50]  J. Mehta,et al.  Inhibition of arterial thrombus formation by ApoA1 Milano. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[51]  M. Jensen-Urstad,et al.  Vascular function correlates with risk factors for cardiovascular disease in a healthy population of 35‐year‐old subjects , 1997, Journal of internal medicine.

[52]  J. Lidfeldt,et al.  Blood pressure in relation to medical, psychological and social variables in a population of 80‐year‐olds. Survival during 6 years , 1997, Journal of internal medicine.

[53]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[54]  D. Stafforini,et al.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. , 1995, The Journal of clinical investigation.

[55]  R. Stocker,et al.  High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Y. Morino,et al.  High density lipoprotein mediates selective reduction in cholesteryl esters from macrophage foam cells. , 1992, Biochimica et biophysica acta.

[57]  A. J. Valente,et al.  Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. , 1991, The Journal of clinical investigation.

[58]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[59]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[60]  G. Norata,et al.  Oxidized-HDL 3 modulates the expression of Cox-2 in human endothelial cells , 2022 .